- Home
- OSUR vs OPP Comparison
OSUR vs OPP Comparison
Compare OSUR & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- OPP
- Stock Information
- Founded
- OSUR 2000
- OPP 2010
- Country
- OSUR United States
- OPP United States
- Employees
- OSUR N/A
- OPP N/A
- Industry
- OSUR Medical/Dental Instruments
- OPP Finance/Investors Services
- Sector
- OSUR Health Care
- OPP Finance
- Exchange
- OSUR Nasdaq
- OPP Nasdaq
- Market Cap
- OSUR 228.1M
- OPP 199.8M
- IPO Year
- OSUR 1986
- OPP N/A
- Fundamental
- Price
- OSUR $3.20
- OPP $8.40
- Analyst Decision
- OSUR Hold
- OPP
- Analyst Count
- OSUR 1
- OPP 0
- Target Price
- OSUR $3.00
- OPP N/A
- AVG Volume (30 Days)
- OSUR 811.4K
- OPP 108.0K
- Earning Date
- OSUR 08-05-2025
- OPP 01-01-0001
- Dividend Yield
- OSUR N/A
- OPP 14.41%
- EPS Growth
- OSUR N/A
- OPP N/A
- EPS
- OSUR N/A
- OPP N/A
- Revenue
- OSUR $161,626,000.00
- OPP N/A
- Revenue This Year
- OSUR N/A
- OPP N/A
- Revenue Next Year
- OSUR $6.80
- OPP N/A
- P/E Ratio
- OSUR N/A
- OPP N/A
- Revenue Growth
- OSUR N/A
- OPP N/A
- 52 Week Low
- OSUR $2.36
- OPP $7.26
- 52 Week High
- OSUR $4.92
- OPP $8.83
- Technical
- Relative Strength Index (RSI)
- OSUR 61.40
- OPP 45.53
- Support Level
- OSUR $3.01
- OPP $8.41
- Resistance Level
- OSUR $3.82
- OPP $8.48
- Average True Range (ATR)
- OSUR 0.17
- OPP 0.06
- MACD
- OSUR 0.02
- OPP -0.01
- Stochastic Oscillator
- OSUR 31.11
- OPP 3.61
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.